RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      SCIE KCI등재

      N-terminal pro-B-type natriuretic peptide as a marker of disease severity in patients with pericardial effusions = N-terminal pro-B-type natriuretic peptide as a marker of disease severity in patients with pericardial effusions

      한글로보기

      https://www.riss.kr/link?id=A76373603

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Background/Aims: N-terminal pro-B-type natriuretic peptide (NT-proBNP) has recently been introduced as a useful marker in diagnosing underlying disease in patients with dyspnea and for determining the prognosis of patients with heart failure. The purpose of this study was to evaluate the value of the NT-proBNP as a marker of disease severity in patients with pericardial effusions. Methods: We enrolled 69 consecutive patients who showed moderate or large pericardial effusion with preserved left ventricular (LV) systolic function; 42 patients finally participated in the study, and 13 (31.0%) of them showed cardiac tamponade. We analyzed the etiologies, the clinical and echocardiographic variables, and the serum NT-proBNP levels in these patients. Results: The mean NT-proBNP level was 751±1002 ng/L (range 5 to 5289), and the median level was 385 ng/L (interquartile range 152 to 844). The NT-proBNP levels were higher in those patients with jugular venous distension (p=0.002), pulsus paradoxus (p=0.016), heart rate ≥100/min (p=0.006), cardiac tamponade (p=0.001), large pericardial effusion (p=0.029), exaggerated respiratory variation of the transmitral inflow (p=0.006), or plethora of the inferior vena cava (p=0.01). The NT-proBNP levels showed significant correlation with heart rate (r=0.517, p<0.001) and the diameter of the inferior vena cava (r=0.329, p=0.03). Conclusions: NT-proBNP may be useful as a marker of disease severity in patients suffering from pericardial effusion, but further prospective studies with more patients will be needed.
      번역하기

      Background/Aims: N-terminal pro-B-type natriuretic peptide (NT-proBNP) has recently been introduced as a useful marker in diagnosing underlying disease in patients with dyspnea and for determining the prognosis of patients with heart failure. The purp...

      Background/Aims: N-terminal pro-B-type natriuretic peptide (NT-proBNP) has recently been introduced as a useful marker in diagnosing underlying disease in patients with dyspnea and for determining the prognosis of patients with heart failure. The purpose of this study was to evaluate the value of the NT-proBNP as a marker of disease severity in patients with pericardial effusions. Methods: We enrolled 69 consecutive patients who showed moderate or large pericardial effusion with preserved left ventricular (LV) systolic function; 42 patients finally participated in the study, and 13 (31.0%) of them showed cardiac tamponade. We analyzed the etiologies, the clinical and echocardiographic variables, and the serum NT-proBNP levels in these patients. Results: The mean NT-proBNP level was 751±1002 ng/L (range 5 to 5289), and the median level was 385 ng/L (interquartile range 152 to 844). The NT-proBNP levels were higher in those patients with jugular venous distension (p=0.002), pulsus paradoxus (p=0.016), heart rate ≥100/min (p=0.006), cardiac tamponade (p=0.001), large pericardial effusion (p=0.029), exaggerated respiratory variation of the transmitral inflow (p=0.006), or plethora of the inferior vena cava (p=0.01). The NT-proBNP levels showed significant correlation with heart rate (r=0.517, p<0.001) and the diameter of the inferior vena cava (r=0.329, p=0.03). Conclusions: NT-proBNP may be useful as a marker of disease severity in patients suffering from pericardial effusion, but further prospective studies with more patients will be needed.

      더보기

      참고문헌 (Reference)

      1 Zipes DP, "text book of cardiovascular medicine" Elservier Saunders 525-, 2005

      2 Mottram PM, "Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function" 92 : 1434-1438, 2003

      3 Tschope C, "The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements" 26 : 2277-2284, 2005

      4 Mair J, "The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure" 39 : 571-588, 2001

      5 Reddy PS, "Spectrum of hemodynamic changes in cardiac tamponade" 66 : 1487-1491, 1990

      6 Maisel AS, "Rapid measurement of B type natriuretic peptide in the emergency diagnosis of heart failure" 347 : 161-167, 2002

      7 Little WC, "Pericardial disease" 113 : 1622-1632, 2006

      8 Vinch CS, "Paradoxical changes in brain natriuretic peptide levels and loading conditions after intravenous conscious sedation" 17 : 1191-1196, 2004

      9 Shaver JA, "Noninvasive/invasive correlates of exaggerated ventricular interdependence in cardiac tamponade" 37 (37): 71-76, 2001

      10 Levin ER, "Natriuretic peptides" 339 : 321-328, 1998

      1 Zipes DP, "text book of cardiovascular medicine" Elservier Saunders 525-, 2005

      2 Mottram PM, "Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function" 92 : 1434-1438, 2003

      3 Tschope C, "The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements" 26 : 2277-2284, 2005

      4 Mair J, "The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure" 39 : 571-588, 2001

      5 Reddy PS, "Spectrum of hemodynamic changes in cardiac tamponade" 66 : 1487-1491, 1990

      6 Maisel AS, "Rapid measurement of B type natriuretic peptide in the emergency diagnosis of heart failure" 347 : 161-167, 2002

      7 Little WC, "Pericardial disease" 113 : 1622-1632, 2006

      8 Vinch CS, "Paradoxical changes in brain natriuretic peptide levels and loading conditions after intravenous conscious sedation" 17 : 1191-1196, 2004

      9 Shaver JA, "Noninvasive/invasive correlates of exaggerated ventricular interdependence in cardiac tamponade" 37 (37): 71-76, 2001

      10 Levin ER, "Natriuretic peptides" 339 : 321-328, 1998

      11 Fernandes F, "NT pro-BNP levels in pericardial diseases and how they are used as complementary evaluation method of diastolic restriction: initial experience: 25 cases" 86 : 175-180, 2006

      12 Gardner RS, "N-terminal pro-brain natriuretic peptide: a new gold standard in predicting mortality in patients with advanced heart failure" 24 : 1735-1743, 2003

      13 Kragelund C, "N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease" 352 : 666-675, 2005

      14 Omland T, "N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes" 106 : 2913-2918, 2002

      15 Spodick DH, "Low atrial natriuretic factor levels and absent pulmonary edema in pericardial compression of the heart" 63 : 1271-1272, 1989

      16 Himelman RB, "Inferior vena cava plethora with blunted respiratory response: a sensitive echocardiographic sign of cardiac tamponade" 12 : 1470-1477, 1988

      17 Min PK, "Incremental value of measuring the time difference between onset of mitral inflow and onset of early diastolic mitral annulus velocity for the evaluation of left ventricular diastolic pressures in patients with normal systolic function and an indeterminate E/E'" 100 : 326-330, 2007

      18 Goetze JP, "Increased cardiac BNP expression associated with myocardial ischemia" 17 : 1105-1107, 2003

      19 Schrier RW, "Hormones and hemodynamics in heart failure" 341 : 577-585, 1999

      20 Hall C, "Essential biochemistry and physiology of (NT-pro) BNP" 6 : 257-260, 2004

      21 Liang F, "Endothelin-dependent and -independent components of strain-activated brain natriuretic peptide gene transcription require extracellular signal regulated kinase and p38 mitogen-activated protein kinase" 35 : 188-192, 2000

      22 Armstrong WF, "Diastolic collapse of the right ventricle with cardiac tamponade: an echocardiographic study" 65 : 1491-1496, 1982

      23 Kronzon I, "Diastolic atrial compression: a sensitive echocardiographic sign of cardiac tamponade" 2 : 770-775, 1983

      24 Ommen SR, "Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study" 102 : 1788-1794, 2000

      25 Sagrista-Sauleda J, "Clinical clues to the causes of large pericardial effusions" 109 : 95-101, 2000

      26 Burstow DJ, "Cardiac tamponade: characteristic Doppler observations" 64 : 312-324, 1989

      27 Goldstein JA, "Cardiac tamponade, constrictive pericarditis, and restrictive cardiomyopathy" 29 : 503-567, 2004

      28 Grose R, "Cardiac tamponade in dogs with normal coronary arteries: I. effect of changing intravascular volume on hemodynamics and myocardial blood flow" 79 : 531-541, 1984

      29 Appleton CP, "Cardiac tamponade and pericardial effusion: respiratory variation in transvalvular flow velocities studied by Doppler echocardiography" 11 : 1020-1030, 1988

      30 Martins JB, "Can cardiac tamponade be diagnosed by echocardiography?: experimental studies" 60 : 737-742, 1979

      31 Hanford DS, "Brain natriuretic peptide is induced by alpha 1-adrenergic agonists as a primary response gene in cultured rat cardiac myocytes" 269 : 26227-26233, 1994

      32 de Lemos JA, "B-type natriuretic peptide in cardiovascular disease" 362 : 316-322, 2003

      33 Gottdiener JS, "American Society of Echocardiography recommendations for use of echocardiography in clinical trials" 17 : 1086-1119, 2004

      34 Spodick DH, "Acute cardiac tamponade" 349 : 684-690, 2003

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2007-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2005-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.37 0.26 1.02
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.83 0.73 0.566 0.13
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼